Zicker, M.; Pinho, J.R.R.; Welter, E.A.R.; Guardia, B.D.; da Silva, P.G.T.M.; da Silveira, L.B.; Camargo, L.F.A. The Risk of Reinfection or Primary Hepatitis E Virus Infection at a Liver Transplant Center in Brazil: An Observational Cohort Study. Viruses2024, 16, 301.
Zicker, M.; Pinho, J.R.R.; Welter, E.A.R.; Guardia, B.D.; da Silva, P.G.T.M.; da Silveira, L.B.; Camargo, L.F.A. The Risk of Reinfection or Primary Hepatitis E Virus Infection at a Liver Transplant Center in Brazil: An Observational Cohort Study. Viruses 2024, 16, 301.
Zicker, M.; Pinho, J.R.R.; Welter, E.A.R.; Guardia, B.D.; da Silva, P.G.T.M.; da Silveira, L.B.; Camargo, L.F.A. The Risk of Reinfection or Primary Hepatitis E Virus Infection at a Liver Transplant Center in Brazil: An Observational Cohort Study. Viruses2024, 16, 301.
Zicker, M.; Pinho, J.R.R.; Welter, E.A.R.; Guardia, B.D.; da Silva, P.G.T.M.; da Silveira, L.B.; Camargo, L.F.A. The Risk of Reinfection or Primary Hepatitis E Virus Infection at a Liver Transplant Center in Brazil: An Observational Cohort Study. Viruses 2024, 16, 301.
Abstract
Hepatitis E virus is a major etiological agent of chronic hepatitis in immunosuppressed individuals. Studies on HEV in the context of liver transplantation have produced mixed results, most of the data coming from studies conducted in high-income countries. This was a prospective cohort study of liver transplant recipients in southeastern Brazil. Recipients were systematically followed for one year, with the objective of determining the prevalence, incidence, genotype, and natural history of HEV infection in this population. We included 107 liver transplant recipients and 83 deceased donors. Positivity for anti-HEV IgG was detected in 11 (10.2%) of the recipients and in eight (9.7%) of the donors. None of the patients tested positive for HEV RNA at baseline or during follow-up. There were no episodes of reactivation or seroconversion, even in cases of serological donor-recipient mismatch or in recipients with acute hepatitis. Acute and chronic HEV infections seem to be rare events in the region studied. That could be attributable to social, economic, and environmental factors. Our data indicate that, among liver transplant recipients, hepatitis E should be investigated only when there are elevated levels of transaminases with no defined cause, as part of the differential diagnosis of seronegative hepatitis after transplantation.
Keywords
hepatitis E; liver transplantation; prevalence; incidence; natural history; Brazil
Subject
Medicine and Pharmacology, Transplantation
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.